0001811288-20-000002.txt : 20200507 0001811288-20-000002.hdr.sgml : 20200507 20200507170342 ACCESSION NUMBER: 0001811288-20-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200507 DATE AS OF CHANGE: 20200507 EFFECTIVENESS DATE: 20200507 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Evozyne, LLC CENTRAL INDEX KEY: 0001811288 IRS NUMBER: 844576299 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-366518 FILM NUMBER: 20857461 BUSINESS ADDRESS: STREET 1: 330 N. WABASH AVENUE STREET 2: SUITE 3500 CITY: CHICAGO STATE: IL ZIP: 60611 BUSINESS PHONE: 312-847-1322 MAIL ADDRESS: STREET 1: 330 N. WABASH AVENUE STREET 2: SUITE 3500 CITY: CHICAGO STATE: IL ZIP: 60611 FORMER COMPANY: FORMER CONFORMED NAME: Evozyne LLC DATE OF NAME CHANGE: 20200504 D 1 primary_doc.xml X0708 D LIVE 0001811288 Evozyne, LLC 330 N. WABASH AVENUE SUITE 3500 CHICAGO IL ILLINOIS 60611 312-847-1322 DELAWARE Evozyne LLC Limited Liability Company true 2019 Jeffrey S. Aronin 330 N. Wabash Avenue Suite 3500 Chicago IL ILLINOIS 60611 Executive Officer Director Chairman of the Board of Managers Patrick J Morris 330 N. Wabash Avenue Suite 3500 Chicago IL ILLINOIS 60611 Executive Officer Director Manager, Interim Chief Executive Officer, Interim President, Executive Vice President, Legal Affairs and General Counsel Aris Theologis 330 N. Wabash Avenue Suite 3500 Chicago IL ILLINOIS 60611 Executive Officer Director Manager and Chief Business Officer Antonio Gracias 330 N. Wabash Avenue Suite 3500 Chicago IL ILLINOIS 60611 Director Manager Rama Ranganathan 110 W. Superior Street Unit 2403 Chicago IL ILLINOIS 60654 Executive Officer Director Manager and Chief Scientific Officer Darien Parhad 330 N. Wabash Avenue Suite 3500 Chicago IL ILLINOIS 60611 Executive Officer Treasurer Biotechnology Decline to Disclose 06b false 2020-04-27 false true false 0 9183673 9183673 0 Offering is closed. false 2 0 0 0 false Evozyne, LLC /s/ PATRICK J. MORRIS Patrick J. Morris EVP, Legal Affairs and General Counsel 2020-05-06